The cardiovascular benefits of SGLT-2 is and GLP-1RAs in type 2 diabetes

Who needs to know?

• General practitioners
• Diabetologists
• Diabetes specialist nurses
• People with type 2 diabetes

Results

SGLT-2is and GLP-1RAs provided similar benefits in reducing major adverse cardiovascular event risk when compared to placebo.